Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Capivasertib plus abiraterone/prednisone improved radiographic PFS in PTEN-deficient mAPMN/S prostate cancer (CAPItello-281) and launched with a VENTANA PTEN ...

For years, national conversations about cancer have often focused on the so-called “Cancer Alley” in the Deep South or Appalachian states with high smoking rates. But recently, a different state has ...

What Is It, and Why Does It Matter? Truqap (capivasertib) is an oral targeted cancer medicine. The FDA has now approved it to be used together with abiraterone and prednisone for a specific type of ...

The relationship between growth and value stocks has undergone a notable reversal, according to a chart from Michael Kantro, chief investment strategist at Piper Sandler. The chart posted by Daily ...

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...

While Western nations might view a 2 percent or 4 percent growth rate as a spectacular success, China faces a shock even with a slight dip in its much higher figures. For decades, China maintained ...

Jill Biden is giving an update on her husband's health a year after former President Joe Biden was diagnosed with cancer. During a June 1 interview on NBC's "Today" to promote her new memoir, the ...

8.9% of patients on combo had little to no cancer at surgery vs 1% on hormone therapy alone Treatment regimen cut disease recurrence or death risk by 20% Researchers call data 'paradigm changing' J&J ...